Orexo
NJ - MorristownPharmaceutical
Focus: Orexo is a specialty pharmaceutical company focused on improved formulations and novel treatments in neurology, particularly opioid-use disorders. The company is publicly traded and operates from its Morristown, NJ headquarters with a concentrated pipeline in addiction medicine and pain management.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Orexo
AI assessmentNot HiringNo open roles listed right now. Follow Orexo to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Orexo's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AiCure monitoring and intervention
Opiate AddictionClinical Trials (1)
NCT02243670Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy
N/AHelp build intelligence for Orexo
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.